BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9829156)

  • 1. Dienogest.
    Foster RH; Wilde MI
    Drugs; 1998 Nov; 56(5):825-33; discussion 834-5. PubMed ID: 9829156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens with antiandrogenic properties.
    Raudrant D; Rabe T
    Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethinylestradiol/dienogest in oral contraception.
    Pérez-Campos EF
    Drugs; 2010 Apr; 70(6):681-9. PubMed ID: 20394455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
    Golbs S; Domhardt R; Radowicky S; Kałuzny Z; Wisser KH; Zimmermann T
    Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):585-92. PubMed ID: 12616705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dienogest: a review of its use in the treatment of endometriosis.
    McCormack PL
    Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
    Rabe T; Kowald A; Ortmann J; Rehberger-Schneider S
    Gynecol Endocrinol; 2000 Aug; 14(4):223-30. PubMed ID: 11075290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of newer progestogens.
    Kuhl H
    Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol valerate/dienogest.
    Wellington K; Perry CM
    Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
    Katsuki Y; Sasagawa S; Takano Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
    Drugs Exp Clin Res; 1997; 23(2):45-62. PubMed ID: 9309380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The endocrinologic profile of metabolites of the progestin dienogest].
    Oettel M; Kaufmann G; Kurischko A
    Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medication of the month. A new combined oral contraceptive containing estradiol valerate and dienogest (Qlaira)].
    Gaspard U; Pintiaux A; Kridelka F
    Rev Med Liege; 2010 Dec; 65(12):706-13. PubMed ID: 21287768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.
    Golbs S; Domhardt R; Presl J; Ganev M; Wisser KH; Zimmermann T
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):689-96. PubMed ID: 12616963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
    Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of a new monophasic oral contraceptive on body metabolism].
    Radowicki S; Skórzewska K; Borakowska B
    Ginekol Pol; 2003 Sep; 74(9):1002-7. PubMed ID: 14674159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.